⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MREO News
Mereo BioPharma Group plc American Depositary Shares
Form 8-K
sec.gov
MREO
4basebio Announces Appointment of Chief Financial Officer and Board Changes
globenewswire.com
NBIX
MREO
Form 8-K/A
sec.gov
MREO
Form 8-K
sec.gov
MREO
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
MREO
Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsight
globenewswire.com
MDT
LIVN
BSX
THC
AMGN
AZN
PFE
JNJ
MRNA
BMY
GILD
REGN
TEVA
CL
PG
KO
PEP
DIS
NVDA
GOOG
AMZN
MSFT
AAPL
TSLA
META
CRM
ADBE
NFLX
INTC
AMD
QCOM
CMCSA
T
VZ
IBM
ORCL
CSCO
ACN
HON
GE
BA
CAT
XOM
CVX
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
MCD
SBUX
COST
WMT
TGT
LOW
CVS
UNH
CI
ETSY
ROKU
PYPL
MELI
EBAY
BABA
JD
PDD
NTES
BIDU
TM
SONY
SAP
AIR
ASML
BNTX
NVO
BP
FCX
BHP
RIO
VALE
NKE
LULU
UA
CROX
NOC
GD
LMT
RTX
AVGO
AMAT
LRCX
MU
NXPI
MRVL
SNPS
CDNS
VRTX
BIIB
LLY
ABBV
MRK
CHTR
CMG
SIRI
GEHC
GSK
SNY
MREO
Pomerantz LLP Advises of Securities Class Action Against Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky
globenewswire.com
MREO
MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO
globenewswire.com
MREO
MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights
globenewswire.com
MREO